Hemodialysis Vascular Grafts Market To Reach $296.15 Million By 2030

Hemodialysis Vascular Grafts Market Growth & Trends

The global hemodialysis vascular grafts market is expected to reach USD 296.15 million by 2030, and is anticipated to register a CAGR of 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Vascular graft is a connection between a vein and an artery that utilizes a hollow, synthetic tube, which is used to remove or return blood during hemodialysis.

Growing healthcare expenditure, advancements in technology, and increasing access to healthcare services in developing countries are the factors contributing to the market growth. Advances in the design and materials used in hemodialysis vascular grafts are leading to better patient outcomes and increased demand for these products. In addition, government initiatives to improve access to healthcare and raise awareness about kidney disease and its treatment options are also contributing to the growth of the market.

Governments and private organizations are also investing more in treating chronic diseases such as CKD and ESRD due to the increase in healthcare expenditure. This increased investment has led to the development of more advanced and effective hemodialysis vascular grafts, which has increased their adoption and growth in the market. In addition, as healthcare systems globally move towards more advanced and specialized care, the demand for grafts is likely to increase, further driving the market growth.

Moreover, governments globally have recognized the growing burden of kidney disease and have begun to invest more in the treatment of this condition. For instance, the U.S. government has invested significant funds in the National Kidney Disease Education Program (NKDEP) to improve the diagnosis, treatment, and management of kidney diseases. This is expected to propel market growth during the forecast period.

Furthermore, the COVID-19 outbreak had a long-term growth potential as it accelerated the adoption of telemedicine and virtual consultations for kidney disease treatment. This may lead to an increase in the number of patients who can access hemodialysis treatment remotely, thus increasing the demand for hemodialysis vascular grafts.

 Request a free sample copy or view report summary: Hemodialysis Vascular Grafts Market Report

Hemodialysis Vascular Grafts Market Report Highlights

• In 2023, the Polytetrafluoroethylene (PTFE) segment held a majority share of the market owing to the increasing incidence of end-stage renal disease (ESRD), aging population as well as growing awareness about the advantages of PTFE over other materials

• This segment is anticipated to grow at the fastest CAGR during the forecast period owing to rising funding and investments for kidney diseases and growing private sector investments in dialysis infrastructure.

• North America held the largest share in 2023 owing to factors such as higher healthcare spending as a portion of GDP, rise in preference for biological and tissue-engineered grafts, and a growing number of patients with CKD.

• The presence of well-defined regulatory guidelines and an increase in the adoption of biological grafts are some of the factors driving the market growth in North America.

Hemodialysis Vascular Grafts Market Segmentation

Grand View Research, Inc. has segmented the global hemodialysis vascular grafts market based on raw material, and region:

Hemodialysis Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2018 - 2030)

• Polyester

• Polytetrafluoroethylene

• Polyurethane

• Biological Materials

  • Human Saphenous & Umbilical Veins

  • Tissue Engineered Materials

Hemodialysis Vascular Grafts Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Hemodialysis Vascular Grafts Market

• W. L. Gore & Associates, Inc.

• C. R. Bard, Inc.

• Vascudyne, Inc.

• LeMaitre

• Getinge AB

• VASCULAR GENESIS

• InnAVasc Medical, Inc.

• CryoLife, Inc.

• Merit Medical Systems

• BIOVIC Sdn Bhd.